Epidural Injection of Corticosteroids Under USG (EICUS)

Sponsor
University of Sao Paulo General Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02860078
Collaborator
(none)
0
1
2

Study Details

Study Description

Brief Summary

Qualitative and quantitatively evaluate the pain control and incidence of adverse effects in patients undergoing corticosteroid infiltration and local anesthetic through sacral epidural puncture with ultrasound assistance or isolated use of fluoroscopy to aid puncture and location of the sacral epidural space. A group will be submitted to epidural corticosteroid infiltration associated with local anesthetic with the use of fluoroscopy for locating the sacral epidural space, which is currently the gold standard for this technique, while in another location group will be held with the use of ultrasound.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrasound
  • Device: Radioscopy
N/A

Detailed Description

Introduction: Procedures guided by ultrasound (USG) have advantages over traditional techniques (fluoroscopy) with respect to regional anesthesia. Some studies have shown its usefulness as a quick, safe and simple tool for the location of the sacral hiatus and to guide the puncture of the sacral epidural space in patients with chronic low back pain, despite the lack of data with respect to clinical outcomes.

OBJECTIVES: Evaluate qualitatively and quantitatively the pain control and incidence of adverse effects in patients undergoing corticosteroid infiltration and local anesthetic through sacral epidural puncture with ultrasound assistance or isolated use of fluoroscopy to aid puncture and location of the sacral epidural space. It will also be evaluated success rate in the first puncture, and the time duration of the procedure in groups.

METHODS: It is clinical, analytical, prospective trial, randomized, covered for evaluators. It will include 30 patients with chronic low back pain or pain in the lower limbs resulting in lumbar canal stenosis, refractory to medical treatment. A group will be submitted to epidural corticosteroid infiltration associated with local anesthetic with the use of fluoroscopy for locating the sacral epidural space, which is currently the gold standard for this technique, while in another location group will be held with the use of ultrasound.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparative Study of the Use of Ultrasonography (USG) or Isolated Use of Fluoroscopy for Sacral Epidural Puncture Corticosteroid Infiltration in Patients With Low Back Pain by Canal Stenosis Lumbar
Actual Study Start Date :
Jan 17, 2021
Actual Primary Completion Date :
Jan 17, 2021
Actual Study Completion Date :
Jan 17, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Ultrasound

The group I will be subjected to epidural infiltration using methylprednisolone acetate diluted in ropivacaine 0.1%. Initially the sacral hiatus is identified by palpation. After, the ultrasound device is used (USG) for the puncture, with a linear transducer of high frequency. At the end of corticosteroid administration, the placement of the needle tip will be checked with fluoroscopy and noted.

Device: Ultrasound
Location and function of sacral epidural space with ultrasound

Active Comparator: Radioscopy

The group II will be subjected to infiltration using methylprednisolone acetate diluted in ropivacaine 0.1% . However, only radioscopy be used to guide the puncture.

Device: Radioscopy
Location and puncture of the sacral epidural space only with fluoroscopy

Outcome Measures

Primary Outcome Measures

  1. Pain management [1 year]

    After infiltration, the patient will be reassessed as to pain control in 15 days, 3, 6 and 12 months. Pain is assessed using a verbal analog scale (VAS) from 0 to 10, with 0 being no pain and 10 being the worst possible pain. Patients will quantify the pain at rest, improvement factors and worse, smaller and higher scores during the day, and average daily pain.

  2. Satisfaction with treatment [during the procedure]

    Satisfaction with the treatment of pain is assessed using a numerical scale from 0 to 10, 0 being unsatisfied and 10 being complete satisfaction.

  3. Medications [3 months]

    It will be noted and all medications used by the patient before the procedure, and their doses, repeating the notes after 3 months of follow-up after the block.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Older than 18 years old;

  • Patients who have low back and/or lower extremities due to lumbar spinal stenosis pain outpatients, with regular follow-up refractory to conservative medical treatment (Verbal Scale of Pain > 3, more three months duration, with no improvement with clinical treatment).

Exclusion Criteria:
  • Symptoms that characterize a surgical emergency;

  • The presence of sensory or motor deficit (chronic mild motor impairment or mild paresthesia will not be deleted), injury to peripheral nerves, trauma history or recent fracture;

  • Serious medical conditions or decompensated;

  • Infection at the puncture site;

  • Coagulopathy;

  • Contrast allergy history or the medications used in the technique;

  • Pregnancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shirley Andrade Santos São Paulo Brazil 05408000

Sponsors and Collaborators

  • University of Sao Paulo General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
SHIRLEY ANDRADE SANTOS, M.D., University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier:
NCT02860078
Other Study ID Numbers:
  • 56795916.8.0000.0068
First Posted:
Aug 9, 2016
Last Update Posted:
Jan 20, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by SHIRLEY ANDRADE SANTOS, M.D., University of Sao Paulo General Hospital

Study Results

No Results Posted as of Jan 20, 2021